Verismo Therapeutics, Inc.

CIK 1855431 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Verismo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 20, 2026D0001855431-26-000003
Jul 14, 2023D0001855431-23-000001
Apr 27, 2021D0001855431-21-000001